Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-30
SponsorBahçeşehir University

About this trial

The purpose of this study is to examine the effects of nomophobia levels on stress, food addiction, and body image among undergraduate students aged 18-30 at Bahçeşehir University, Faculty of Health Sciences. The primary questions it aims to answer are:

* Is there a statistically significant relationship between nomophobia levels and perceived stress, food addiction, and body image among university students? * Is there a correlation between objective anthropometric data (body fat percentage, skeletal muscle mass) measured via Bioelectrical Impedance Analysis (BIA), waist/hip circumference measurements, and the individual's perceived body image?

Eligibility criteria

Qualifiers

Being an active smartphone user

Reading and providing consent via the Informed Consent Form

Absence of conditions such as pacemaker implantation, metallic prostheses in the body, or pregnancy

Not having a diagnosed metabolic disorder (e.g., Cushing's syndrome, diabetes, thyroid disorders) or any acute/chronic psychiatric condition that may affect eating behavior

Disqualifiers

Individuals with a current diagnosis of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder, etc.)

Individuals with a psychiatric diagnosis of severe depression, bipolar disorder, psychotic disorder, or an anxiety disorder requiring treatment

Individuals who regularly use psychiatric medications (e.g., SSRIs, SNRIs, antipsychotics, mood stabilizers, etc.)

Individuals who have used corticosteroids or similar hormone-regulating medications in the past 3 months

Trial design

Treatments tested in this trial

  • Questionnaires on Nomophobia, Perceived Stress, Body Image, and Food Addiction; Body Composition and Anthropometric Measurements via Bioelectrical Impedance Analysis

Treatment groups

150 Participants
are divided into 1 treatment group

Sponsors and collaborators